Clinical Takeaway In a controlled crossover trial of 25 healthy males, CBD at both low and high single doses showed no direct effect on cortical excitability compared to placebo, suggesting CBD alone...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized controlled trial of healthy males, CBD at both low (30 mg) and high (700 mg) single doses showed no direct effect on cortical excitability compared to placebo,...
`Cannabinoid Clinical Trials: CBD Cortical Excitability Study`
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy adults, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability or sedation compared to...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy males, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This...
Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence
Clinical Takeaway Plant-derived cannabidiol (CBD) oral solution produced meaningful reductions in drop seizures in patients with Lennox-Gastaut syndrome even at thresholds below the standard 50% benchmark used in clinical trials. Caregiver-reported outcomes...
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Clinical Takeaway Cannabinoids have been studied across a range of pediatric medical conditions, with evidence drawn from interventional trials, observational studies, and patient surveys. The current body of research supports cautious clinical...
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinical Takeaway Plant-derived cannabidiol (CBD) oral solution produced meaningful reductions in drop seizures in patients with Lennox-Gastaut syndrome at thresholds below the traditional 50% benchmark used in clinical trials. Caregiver-reported outcomes aligned...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this rigorous crossover trial, neither a low nor a high single dose of CBD directly altered cortical excitability or produced measurable sedation in healthy adults. This suggests that CBD’s...